The Endocannabinoid System: Your Body's Built-In Cannabis Network

In 1964, the Israeli chemist Raphael Mechoulam isolated tetrahydrocannabinol — THC — from a brick of Lebanese hashish. It was the first time anyone had figured out, with chemical precision, what the active ingredient in cannabis actually was.

That should have been the end of the story. It was the beginning.

For the next three decades, researchers tried to understand how a single plant molecule could produce such specific and consistent effects in human brains. The question implied something stranger than the answer most people expected: if THC was acting on something specific in the brain, then that something must have been there before humans ever encountered the plant. Brains do not evolve receptors for substances they have never met.

In 1988, Allyn Howlett and her team at St. Louis University identified what they were looking for. They found a receptor — a tiny lock embedded in the membranes of neurons throughout the brain — that fit THC the way a key fits a deadbolt. They called it CB1.

A few years later they found a second one, CB2, mostly in the immune system.

And then came the real discovery: the body was making its own keys.

The Body Makes Its Own Cannabinoids

In 1992, Mechoulam's lab — collaborating with American researchers Bill Devane and Lumír Hanuš — isolated a molecule from pig brain tissue that bound to the CB1 receptor exactly the way THC did. It was a fatty-acid derivative the body produced on its own. Mechoulam named it anandamide, from the Sanskrit ananda, meaning bliss.

A second internal cannabinoid, 2-AG, was identified in 1995. It turned out to be far more abundant than anandamide. There are now more than a half-dozen well-characterized endocannabinoids in the human body.

What this meant, mechanically, was that humans (and almost every other vertebrate) carry an entire signaling system — receptors, messenger molecules, enzymes that build them, enzymes that break them down — that the cannabis plant happens to plug into. The system has nothing to do with cannabis in evolutionary terms. The plant is, biochemically speaking, a happy accident.

What the System Actually Does

The endocannabinoid system is one of the most pervasive signaling networks in the body. CB1 receptors are dense in the hippocampus (memory), the basal ganglia (movement), the cerebellum (coordination), the hypothalamus (appetite and temperature regulation), and the prefrontal cortex (executive function and mood). CB2 receptors are concentrated in the spleen, the gut, and immune cells.

What the system does, in broad terms, is modulate. It is a tuning system rather than an on/off switch. Endocannabinoids are released on demand, locally, and broken down quickly. They act as a kind of neurochemical brake — telling other systems to back off, slow down, calm down. This is why the effects of cannabis are so diffuse and so individual: the plant is hitting a regulator, and the regulator is touching everything.

Researchers have linked endocannabinoid signaling to pain, mood, appetite, sleep, immune response, fertility, motor control, memory, and the body's response to stress. There is now a small but growing literature on what is sometimes called "clinical endocannabinoid deficiency" — the hypothesis that some chronic conditions, including migraine and irritable bowel syndrome, may involve dysregulation of this system.

The Strange Order of Events

The remarkable thing about the discovery is how it ran backwards. Most pharmacology starts with a body system and looks for drugs that affect it. The endocannabinoid system was discovered the other way around. Humans had been using cannabis for thousands of years before anyone realized that the reason it worked was because the plant was, by chemical coincidence, copying a signal we were already sending to ourselves.

The receptors were named after the plant. The system was named after the plant. But the system came first by hundreds of millions of years.

We just didn't know we had it.